Abstract: An extended fibre point (1) is coated with photbiotin and irradiated with U.V. light, causing the photobiotin to bind with the fibre pint. The fibre point is then brounght into contact with streptavidin and submerged in a solution containing dyed copies of the DNA molecule to be sequenced. Biotin is also bonded to the 5′ end of the dyed DNA molecules (4A). the biotin coupled to individual DNA molecules binds with the streptavidin at the fibre point. Light is coupled into the fibre to detect the thus obtained bonds. The evanescent field of said light excites a dyed DNA molecule to emit fluorescent light as soon as it binds with the fibre point. When a bond is deteccted, the fibre is immediately remvoded from the solution, and the fibre point is inserted into a microcapillary (5). The microcapillary is filled with a buffer solution containing exonucleases which decompose the DNA colecule base after base.
Abstract: The present invention provides an optical fluorescence based sensor for measuring the concentration of a gas (e.g., CO2 or ammonia) in a medium such as blood which has superior dry web sensor performance, enhanced sensor consistency for transparent sensor calibration, improved autoclave stability and rapid rehydration of the sensor. In a preferred embodiment, the sensors of the present invention comprise microcompartments of an aqueous phase having a pH sensitive indicator component and a nonionic amphipathic surfactant within a hydrophobic barrier phase comprising a plurality of dispersed hydrophobic particles.
Type:
Grant
Filed:
October 3, 1997
Date of Patent:
April 17, 2001
Assignee:
Terumo Cardiovascular Systems Corporation
Inventors:
Kathryn R. Bretscher, James A. Baker, Kenneth B. Wood, Mai T. Nguyen, Monica A. Hamer, Christopher J. Rueb
Abstract: In accordance with the present invention, a method of conducting an assay of a sample containing an analyte of interest includes the step of forming a mixture so as to bring a metal-ligand complex into interactive proximity with the sample containing the analyte of interest. The mixture is irradiated with electromagnetic light energy so as to cause emission of light indicative of the analyte of interest. The emitted light is measured, and the measurement of the emitted light is utilized to measure the analyte of interest. The metal-ligand complex can be [Re(bcp)(CO)3(4-COOHPy)]+, [Os(phen)2(aphen)]2+, [Os(tpy)(triphos)]2+, [Os(tppz)2]2+, and [Os(ttpy)2]2+, or the like. Also, the present invention is directed to a metal-ligand complex of the formula [Re(bcp)(CO)3(4-COOHPy)]+.
Type:
Grant
Filed:
January 14, 1998
Date of Patent:
April 10, 2001
Inventors:
Joseph R. Lakowicz, Felix Castellano, Zakir Murtaza
Abstract: Method for specific detection of one or more analytes in a sample. The method includes specifically associating any one or more analytes in the sample with a scattered-light detectable particle, illuminating any particle associated with the analytes with light under conditions which produce scattered light from the particle and in which light scattered from one or more particles can be detected by a human eye with less than 500 times magnification and without electronic amplification. The method also includes detecting the light scattered by any such particles under those conditions as a measure of the presence of the analytes.
Type:
Grant
Filed:
April 18, 1997
Date of Patent:
April 10, 2001
Assignee:
Genicon Sciences Corporation
Inventors:
Juan Yguerabide, Evangelina E. Yguerabide, David E. Kohne, Jeffrey T. Jackson
Abstract: A liquid permeable metallic coating is utilized in conjunction with a fluorescence based optical sensor. The metallic coating is deposited directly on, and is in physical contact with, the sensing membrane. The metallic coating does not require an intervening substrate layer or other components. When light from a light source is shone through the substantially light transmissive substrate onto the sensing membrane, the metallic overcoating reflects back the excitation light as well as the fluorescence light generated by the sensor such that substantially no light reaches the sample where the light may be scattered and/or absorbed by the sample. Accordingly, the accuracy and repeatability of the sensor is improved while the cost and production times associated with manufacturing the sensor are minimized.
Type:
Grant
Filed:
August 21, 1998
Date of Patent:
March 27, 2001
Assignee:
Bayer Corporation
Inventors:
Kevin J. Sullivan, Thomas C. Collins, Rudolf E. Slovacek
Abstract: Materials and methods are provided for producing patterned multi-array, multi-specific surfaces for use in diagnostics. The invention provides for electrochemiluminescence methods for detecting or measuring an analyte of interest. It also provides for novel electrodes for ECL assays. Materials and methods are provided for the chemical and/or physical control of conducting domains and reagent deposition for use multiply specific testing procedures.
Type:
Grant
Filed:
September 17, 1996
Date of Patent:
March 27, 2001
Assignee:
Meso Scale Technologies, LLC
Inventors:
Jacob N. Wohlstadter, James Wilbur, George Sigal, Mark Martin, Liang-Hong Guo, Alan Fischer, Jon Leland, Mark A. Billadeau
Abstract: The invention described in detail herein relates to the detection, determination, and quantitation of certain ions and small molecules in solution. The invention specifically relates to improvements in the area of photoluminescent sensors for use in a detection scheme involving the alteration of a photoluminescent label or moiety attached to or associated with an analyte binding macromolecule. One may use the changes in photoluminescence lifetime, changes in ratios of photoluminescence intensity or changes in photoluminescence polarization (anisotropy) to determine the analyte. The photoluminescence change measured correlates to the concentration of the ion or molecule in solution.
Type:
Grant
Filed:
March 19, 1999
Date of Patent:
March 6, 2001
Assignee:
University of Maryland, Baltimore
Inventors:
Richard B. Thompson, Vincent L. Feliccia, Badri P. Maliwal, Carol A. Fierke
Abstract: Optical sensor formulations comprising polymeric sensing formulations and methods of predictably making optical sensor formulations, for, e.g., measuring O2 levels in patient blood samples. These formulations may be, e.g., deposited as a membrane on light-transmissive substrates. In an embodiment, O2-sensing formulations may be made by a process including selecting a first homopolymer comprised of first monomeric units, the first homopolymer having a first PermO2 value; selecting a second homopolymer comprised of second monomeric units, the second homopolymer having a second PermO2 value that is different from the first PermO2 value; and copolymerizing the first and second monomeric units to obtain a copolymer having an intermediate PermO2 value, i.e., between the two PermO2 values, the intermediate PermO2 providing the desired PermO2 for the desired oxygen sensing formulation.
Type:
Grant
Filed:
January 21, 1998
Date of Patent:
February 20, 2001
Assignees:
Bayer Corporation, Novartis AG
Inventors:
Joseph Berger, Thomas C. Collins, Rudolf E. Slovacek
Abstract: The invention relates to a compound having the general Formula I:
including its salts, where Z is either the group having the general Formula II:
where
R1 is alkyl having 1-4 C atoms, alkoxyalkyl having 2-5 C atoms or aryloxyalkyl whose alkyl group has 1-4 C atoms,
R2 is alkyl having 1-4 C atoms or alkoxyalkyl having 2-5 C atoms,
R3 is H, alkoxy having 1-4 C atoms, halogen, NO or NO2,
Y is H2 or O and
L is a luminophoric moiety in a position para or meta to the nitrogen,
or is the group having the general Formula III:
where
n is 2 or 3,
R4 is alkyl having 1-4 C atoms or alkoxyalkyl having 2-5 C atoms,
R5 is H, alkoxy having 1-4 C atoms, halogen, NO or NO2 and
L is a luminophoric moiety in a position para or meta to the nitrogen,
or is the group having the general Formula IV:
where
R6 is alkyl having 1-3 C atoms or phenyl,
R7 is H, alkoxy having 1-4 C atoms, halogen, NO or NO2 and
L is a luminophoric moiety in a position para